BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 29520051)

  • 1. Cabozantinib Affects Osteosarcoma Growth Through A Direct Effect On Tumor Cells and Modifications In Bone Microenvironment.
    Fioramonti M; Fausti V; Pantano F; Iuliani M; Ribelli G; Lotti F; Pignochino Y; Grignani G; Santini D; Tonini G; Vincenzi B
    Sci Rep; 2018 Mar; 8(1):4177. PubMed ID: 29520051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of Osteoblast Migration Involving Receptor Activator of Nuclear Factor-kappa B (RANK) Signaling.
    Golden D; Saria EA; Hansen MF
    J Cell Physiol; 2015 Dec; 230(12):2951-60. PubMed ID: 25893522
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dual targeting c-met and VEGFR2 in osteoblasts suppresses growth and osteolysis of prostate cancer bone metastasis.
    Lee C; Whang YM; Campbell P; Mulcrone PL; Elefteriou F; Cho SW; Park SI
    Cancer Lett; 2018 Feb; 414():205-213. PubMed ID: 29174801
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteoprotegerin activates osteosarcoma cells that co-express RANK and RANKL.
    Marley K; Bracha S; Seguin B
    Exp Cell Res; 2015 Oct; 338(1):32-8. PubMed ID: 26254896
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular mechanisms underlying the inhibitory effects of bovine lactoferrin on osteosarcoma.
    Chea C; Haing S; Miyauchi M; Shrestha M; Imanaka H; Takata T
    Biochem Biophys Res Commun; 2019 Jan; 508(3):946-952. PubMed ID: 30545626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The MET oncogene transforms human primary bone-derived cells into osteosarcomas by targeting committed osteo-progenitors.
    Dani N; Olivero M; Mareschi K; van Duist MM; Miretti S; Cuvertino S; Patané S; Calogero R; Ferracini R; Scotlandi K; Fagioli F; Di Renzo MF
    J Bone Miner Res; 2012 Jun; 27(6):1322-34. PubMed ID: 22367914
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid modification of the bone microenvironment following short-term treatment with Cabozantinib in vivo.
    Haider MT; Hunter KD; Robinson SP; Graham TJ; Corey E; Dear TN; Hughes R; Brown NJ; Holen I
    Bone; 2015 Dec; 81():581-592. PubMed ID: 26279137
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CXCR1/Akt signaling activation induced by mesenchymal stem cell-derived IL-8 promotes osteosarcoma cell anoikis resistance and pulmonary metastasis.
    Du L; Han XG; Tu B; Wang MQ; Qiao H; Zhang SH; Fan QM; Tang TT
    Cell Death Dis; 2018 Jun; 9(7):714. PubMed ID: 29915309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic RANK-Fc protein therapy is efficacious against primary osteosarcoma growth in a murine model via activity against osteoclasts.
    Akiyama T; Dass CR; Shinoda Y; Kawano H; Tanaka S; Choong PF
    J Pharm Pharmacol; 2010 Apr; 62(4):470-6. PubMed ID: 20604836
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The orally bioavailable met inhibitor PF-2341066 inhibits osteosarcoma growth and osteolysis/matrix production in a xenograft model.
    Sampson ER; Martin BA; Morris AE; Xie C; Schwarz EM; O'Keefe RJ; Rosier RN
    J Bone Miner Res; 2011 Jun; 26(6):1283-94. PubMed ID: 21308771
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Homotypic RANK signaling differentially regulates proliferation, motility and cell survival in osteosarcoma and mammary epithelial cells.
    Beristain AG; Narala SR; Di Grappa MA; Khokha R
    J Cell Sci; 2012 Feb; 125(Pt 4):943-55. PubMed ID: 22421365
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integrating Murine and Clinical Trials with Cabozantinib to Understand Roles of MET and VEGFR2 as Targets for Growth Inhibition of Prostate Cancer.
    Varkaris A; Corn PG; Parikh NU; Efstathiou E; Song JH; Lee YC; Aparicio A; Hoang AG; Gaur S; Thorpe L; Maity SN; Bar Eli M; Czerniak BA; Shao Y; Alauddin M; Lin SH; Logothetis CJ; Gallick GE
    Clin Cancer Res; 2016 Jan; 22(1):107-21. PubMed ID: 26272062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Caprin-1, a novel Cyr61-interacting protein, promotes osteosarcoma tumor growth and lung metastasis in mice.
    Sabile AA; Arlt MJ; Muff R; Husmann K; Hess D; Bertz J; Langsam B; Aemisegger C; Ziegler U; Born W; Fuchs B
    Biochim Biophys Acta; 2013 Aug; 1832(8):1173-82. PubMed ID: 23528710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DU145 human prostate cancer cells express functional receptor activator of NFkappaB: new insights in the prostate cancer bone metastasis process.
    Mori K; Le Goff B; Charrier C; Battaglia S; Heymann D; Rédini F
    Bone; 2007 Apr; 40(4):981-90. PubMed ID: 17196895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Caffeine induces apoptosis of osteosarcoma cells by inhibiting AKT/mTOR/S6K, NF-κB and MAPK pathways.
    Miwa S; Sugimoto N; Yamamoto N; Shirai T; Nishida H; Hayashi K; Kimura H; Takeuchi A; Igarashi K; Yachie A; Tsuchiya H
    Anticancer Res; 2012 Sep; 32(9):3643-9. PubMed ID: 22993301
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor agent cabozantinib decreases RANKL expression in osteoblastic cells and inhibits osteoclastogenesis and PTHrP-stimulated bone resorption.
    Stern PH; Alvares K
    J Cell Biochem; 2014 Nov; 115(11):2033-8. PubMed ID: 25042887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interaction between human osteosarcoma and mesenchymal stem cells via an interleukin-8 signaling loop in the tumor microenvironment.
    Kawano M; Tanaka K; Itonaga I; Iwasaki T; Tsumura H
    Cell Commun Signal; 2018 Apr; 16(1):13. PubMed ID: 29625612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phyllanthus urinaria suppresses human osteosarcoma cell invasion and migration by transcriptionally inhibiting u-PA via ERK and Akt signaling pathways.
    Lu KH; Yang HW; Su CW; Lue KH; Yang SF; Hsieh YS
    Food Chem Toxicol; 2013 Feb; 52():193-9. PubMed ID: 23201449
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sensitivity of osteosarcoma cells to HDAC inhibitor AR-42 mediated apoptosis.
    Murahari S; Jalkanen AL; Kulp SK; Chen CS; Modiano JF; London CA; Kisseberth WC
    BMC Cancer; 2017 Jan; 17(1):67. PubMed ID: 28109246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of Tumor- and Bone Marrow-Derived Mesenchymal Stromal/Stem Cells from Patients with High-Grade Osteosarcoma.
    Le Nail LR; Brennan M; Rosset P; Deschaseaux F; Piloquet P; Pichon O; Le Caignec C; Crenn V; Layrolle P; Hérault O; De Pinieux G; Trichet V
    Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29494553
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.